
Medically supervised Tirzepatide & Retatrutide weight loss programs — personally tailored, clinically proven, and now available at an unprecedented value.
Get a full year of medically supervised GLP-1 weight loss therapy — including your personalized treatment plan, ongoing medical oversight, and all medication — for one straightforward price.
The most powerful FDA-approved weight loss therapy available. Tirzepatide targets two receptors — GLP-1 and GIP — delivering up to 22.5% body weight reduction in clinical trials. Medically supervised, personally dosed.
The next frontier in metabolic medicine. Retatrutide is the only triple agonist targeting GLP-1, GIP, and Glucagon receptors simultaneously — delivering up to 24% body weight loss in clinical trials.

No hidden fees. No surprise charges. Just a full year of medically supervised weight loss therapy at a price that makes sense.
Fill out the form and our medical team will reach out to discuss which treatment is right for you. There is no obligation — just a conversation about your goals and how we can help you achieve them.
*Based on clinical trial results for Retatrutide at highest dose.